🇺🇸 FDA
Patent

US 10363244

Compositions comprising metformin and a glucokinase activator

granted A61KA61K31/155A61K31/426

Quick answer

US patent 10363244 (Compositions comprising metformin and a glucokinase activator) held by VTV THERAPEUTICS LLC expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VTV THERAPEUTICS LLC
Grant date
Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/155, A61K31/426, A61P, A61P3/00